CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
48 hedge funds and large institutions have $43.3M invested in Carisma Therapeutics in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.45% less ownership
Funds ownership: 2.42% → 1.97% (-0.45%)
46% less capital invested
Capital invested by funds: $80.2M → $43.3M (-$36.9M)
Holders
48
Holding in Top 10
1
Calls
$467K
Puts
$357K
Top Buyers
| 1 | +$1.13M | |
| 2 | +$383K | |
| 3 | +$284K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$255K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$245K |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$2.53M | |
| 3 | -$1.35M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$414K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$181K |